Loading stock data…
$5.08+0.07 (+1.40%)
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide.
Nu Skin Enterprises, Inc. in the Consumer Defensive sector is trading at $5.08 with a market capitalization of $231M. Wall Street consensus targets $12.77 (1 analysts), implying a +151.4% move over the next 12 months. The stock is currently near its 52-week low of $4.45, remaining 22.8% below its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 79 is overbought against a weak tape. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $320.11M↓ | $320.61M↓ | $370.32M↑ | $364.21M↓ | $386.14M |
| Gross Profit | $218.32M↑ | $214.46M↓ | $261.98M↑ | $256.72M↓ | $265.73M |
| Operating Income | $19.56M↑ | $5.87M↓ | $23.24M↑ | $21.64M↓ | $30.78M |
| Net Income | -$249.80M↓ | $1.84M↓ | $14.49M↓ | $17.08M↓ | $21.12M |
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiS...